RT @ThomasCiullaMD: Just co-authored this paper on integrin inhibition, a potentially important pathway for treatment of common causes of v… Source by Thomas Ciulla, MD, MBA Return to main website.
RT @PharmacDaily: Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspen… Source by Thomas Ciulla, MD, MBA Return to main website.
RT @ThomasCiullaMD: Just published-With clinical trials from small molecules to #genetherapy to viral nanoparticles, for disorders from #ma…
Source by Thomas Ciulla, MD, MBA
RT @ThomasCiullaMD: I have great fun & satisfaction mentoring @IU_Health residents interested in #research. Congrats to this fantastic IU… Source by Thomas Ciulla, MD, MBA Return to main website.
RT @ThomasCiullaMD: Just published…Understanding the #genetic basis for this common cause of #vision loss will facilitate early detection… Source by Thomas Ciulla, MD, MBA Return to main website.
Just published-With clinical trials from small molecules to #genetherapy to viral nanoparticles, for disorders from #macular edema to #AMD to #diabeticretinopathy to choroidal melanoma, an understanding of #suprachoroidal drug delivery becomes essential… https://t.co/4qIjnVZ9RP
Source by Thomas Ciulla, MD, MBA
Just published…Understanding the #genetic basis for this common cause of #vision loss will facilitate early detection, prognosis & treatment, perhaps even a #PrecisionMedicine approach like #gene therapy someday: #eyes #glaucoma #Ophthalmology #biotech https://t.co/1REz7x85tQ Source by Thomas Ciulla, MD, MBA Return to main website.
RT @ThomasCiullaMD: Honored to present on Suprachoroidal Drug Delivery & Clearside’s preclinical and clinical research programs at the rece… Source by Thomas Ciulla, MD, MBA Return to main website.
RT @ThomasCiullaMD: Just published on suprachoroidal drug delivery: “Clinical Characterization of Suprachoroidal Injection Procedure Utiliz…
Source by Thomas Ciulla, MD, MBA
RT @ThomasCiullaMD: Honored to be listed here and thankful for those patients, colleagues & mentors who inspire us… Source by Thomas Ciulla, MD, MBA Return to main website.